Location: 1180 Postle Hall
Living Well to 100: The Role of Inflammation
Kenneth S. Kornman, DDS, PhD
Editor-in-Chief of the Journal of Periodontology
Adjunct Research Professor, Department of Periodontics and Oral Medicine
University of Michigan
A surprising number of people do not have a first experience with a major chronic disease of aging until their mid-70’s or later, but many others have major medical events 20 years earlier. Much is now known about aging well. For example, individuals with chronic inflammatory diseases have a 20-30% higher frequency of heart disease, type 2 diabetes, and stroke than those without any chronic inflammatory diseases. Low grade chronic inflammation is one major determinant of your aging path, and moderate to severe periodontitis is one of the most prevalent chronic inflammatory diseases, second only to obesity. Low grade chronic inflammation is a major driver in multiple diseases, including various cancers, and new anti-inflammatory drugs reduce cardiovascular diseases, lung cancer, and progression of heart failure. It is now possible to help identify which patients and family members are on a more rapid chronic disease path and intervene to help many live well longer.
Dr. Kornman is Editor-in-Chief of the Journal of Periodontology, and an Adjunct Research Professor in the Dept of Periodontics and Oral Medicine at the University of Michigan. Previously, Dr Kornman was cofounder and Chief Scientific Officer of Interleukin Genetics, a diagnostics company focused on chronic inflammatory diseases, including periodontitis, cardiovascular disease, and osteoarthritis. Dr. Kornman is currently CEO of a molecular diagnostics company based in London. Prior to entering industry, he was Professor and Chairman of Periodontology and Professor of Microbiology and Immunology at the University of Texas Health Science Center at San Antonio. Dr. Kornman has published extensively including papers in Science, New England Journal of Medicine, Journal of American College of Cardiology, Human Molecular Genetics, Annals of Rheumatic Diseases, and various dental journals. Much of Dr. Kornman’s career has focused on translating research into clinical use and includes several issued U.S. patents and multiple years of responsibility for assessment of new technology generated within the Division of Genomic Medicine at the University of Sheffield Medical School in the UK. Dr. Kornman received his DDS from Emory University and a specialty in periodontology and a PhD from the University of Michigan. His mentors were Sig Ramfjord and Harald Loe.
Lunch will be provided. For more information: 614-688-3435 or email@example.com.
One CE credit available.